A detailed history of Aveo Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 4,229 shares of MRK stock, worth $415,879. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,229
Previous 4,866 13.09%
Holding current value
$415,879
Previous $602,000 20.27%
% of portfolio
0.05%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $70,802 - $82,153
-637 Reduced 13.09%
4,229 $480,000
Q2 2024

Aug 02, 2024

SELL
$123.8 - $132.96 $228,163 - $245,045
-1,843 Reduced 27.47%
4,866 $602,000
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $21,968 - $25,598
194 Added 2.98%
6,709 $885,000
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $27,449 - $29,871
274 Added 4.39%
6,515 $710,000
Q3 2023

Nov 06, 2023

SELL
$102.95 - $114.33 $3,809 - $4,230
-37 Reduced 0.59%
6,241 $642,000
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $836,079 - $911,289
-7,698 Reduced 55.08%
6,278 $724,000
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $106,954 - $119,339
-1,039 Reduced 6.92%
13,976 $1.49 Million
Q4 2022

Feb 03, 2023

SELL
$87.44 - $112.11 $373,718 - $479,158
-4,274 Reduced 22.16%
15,015 $1.67 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $327,469 - $367,875
-3,874 Reduced 16.72%
19,289 $1.66 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $369,944 - $419,349
-4,431 Reduced 16.06%
23,163 $2.11 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $658,208 - $737,809
-8,954 Reduced 24.5%
27,594 $2.26 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $2.3 Million - $2.88 Million
31,849 Added 677.78%
36,548 $2.8 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $4,157 - $4,572
58 Added 1.25%
4,699 $353,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $3,796 - $4,199
54 Added 1.18%
4,641 $361,000
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $315,860 - $372,051
4,587 New
4,587 $354,000
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $256,290 - $284,430
-3,571 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $261,325 - $296,214
3,571 New
3,571 $296,000
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $192,317 - $218,835
-2,731 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $6,399 - $8,869
101 Added 3.84%
2,731 $210,000
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $8,921 - $10,067
115 Added 4.57%
2,630 $239,000
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $684 - $746
9 Added 0.36%
2,515 $211,000
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $6,355 - $7,424
91 Added 3.77%
2,506 $205,000
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $168,035 - $191,654
2,415 New
2,415 $201,000
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $211,834 - $245,830
-3,247 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $60,862 - $71,571
-1,055 Reduced 24.52%
3,247 $236,000
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $4,218 - $4,956
83 Added 1.97%
4,302 $261,000
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $215,000 - $249,891
4,219 New
4,219 $230,000
Q4 2017

Feb 05, 2018

SELL
$51.62 - $61.64 $162,190 - $193,672
-3,142 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $184,341 - $198,354
3,142
3,142 $201,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Aveo Capital Partners, LLC Portfolio

Follow Aveo Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.